Plaintiffs’ attorneys involved in the federal multidistrict litigation (MDL) for all Zantac cancer lawsuits filed throughout the federal court system have notified the Court that they only intend to move forward with expert support that establishes five different types of cancer may be caused by Zantac, including bladder cancer, esophageal cancer, gastric cancer, liver cancer…
The U.S. District Judge presiding over all federal litigation involving kidney problems from proton pump inhibitors (PPI) has scheduled a bellwether trial for early next year, which will be the first out of more than 13,000 Nexium lawsuits, Prilosec lawsuits and other claims filed against manufacturers of the popular proton pump inhibitor heartburn drugs to…
Plaintiffs are pushing back against an attempt by generic drug manufacturers and repackagers to dismiss ranitidine class action lawsuits filed over the risk of cancer from high levels of the chemical byproduct found in all versions of the heartburn drug, which was more commonly known by the brand name Zantac. Over the past year, ranitidine…
In September 2019, the FDA warned that the popular heartburn drug Zantac may contain cancer-causing impurities. These same chemicals have been linked to an increased risk of colorectal cancer, stomach cancer, liver cancer and other health problems. STATUS OF ZANTAC LAWSUITS: Lawyers are investigating whether individuals diagnosed with cancer in recent years may be entitled to…
